This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Griffiths, J. C. Articles by Power, R. Search for Related Content PubMed PubMed Citation Articles by Griffiths, J. C. Articles by Power, R. Social Bookmarking                         What's this?

Acute and Subchronic Toxicity Studies on Sel-Plex^®, a Standardized, Registered High-selenium Yeast

Burdock Group, Vero Beach, Florida, USA

Ronan Power

North American BioSciences Center, Alltech Inc., Nicholasville, Kentucky, USA

Correspondence: Address correspondence to James C. Griffiths, Director of Toxicology, Burdock Group, 2001 9th Avenue, Suite 301, Vero Beach, FL 32960, USA. E-mail:jgriffiths{at}burdockgroup.com

Selenium has been recognized as an essential nutrient for human health; however, its bioavailability is primarily dependent upon the type of selenium, elemental versus organic. In geographic areas low in selenium, there is the potential for animals (including humans) to become selenium deficient and this potential deficiency can be remedied by consumption of exogenous selenium, including selenium-enriched yeast (Saccharomyces cerevisiae) that contains high levels of organic selenium (e.g., selenized yeast). The present studies were conducted to investigate potential oral toxicity of a unique selenized yeast preparation (Sel-Plex^®) when administered to (1) adult female CHS Swiss mice ICo:OFI (IOPS Caw); (2) adult female CHS Sprague-Dawley rats; and (3) adult male and female Sprague-Dawley CD rats. For the 28- and 90-day toxicity studies, (1) adult male and female Sprague-Dawley CRL:CD^® (SD) IGS BR strain rats and (2) adult male and female 6- to 7-month-old Beagle dogs were used. The LD₅₀ for mice was ^® 2000 mg Sel-Plex® /kg (4.06 mg Se/kg) and for rats, was greater ^® than 2000 mg Sel-Plex® /kg (4.06 mg Se/kg). In the two 28-day studies, for rats, the no observed adverse effects level (NOAEL) was 50 mg Sel-Plex^®/kg/day (0.1 mg Se/kg/day), and for the dogs, the NOAEL was 22.5 mg Sel-Plex^®/kg/day (0.045 mg Se/kg/day). For the two 90-day studies, for rats the NOAEL for Sel-Plex^® was 114 mg/kg/day (0.23 mg Se/kg/day), and for dogs, the NOAEL was 30 mg Sel-Plex^®/kg/day (0.06 mg Se/kg/day): the latter being the NOAEL in the most sensitive species.

Key Words: Acute Toxicity • Saccharomyces cerevisiae • Selenium • Subchronic Toxicity • Yeast

International Journal of Toxicology, Vol. 25, No. 6, 465-476 (2006)
DOI: 10.1080/10915810600959626


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?